Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia  E.V. Lemos, F.P.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France  D.
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis  E.V. Lemos, F.P. de la Hoz,
Gut bacterial microbiota and obesity
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Herpes zoster in non-hospitalized children
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit  A. Tsakris, A. Ikonomidis,
R. Cantón  Clinical Microbiology and Infection 
A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents  S. Brown, S.G.B. Amyes  Clinical.
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure  Y.-C. Wang, Y.-T.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii  M. Bernabeu-Wittel, A. García-Curiel,
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Vector control: a cornerstone in the malaria elimination campaign
A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia  S.-C. Kuo, Y.-T. Lee,
Community-acquired pneumonia: the evolving challenge
CMI editorial report 2011 Clinical Microbiology and Infection
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study  V.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Abstracts cont. Clinical Microbiology and Infection
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci  H.L. DuPont, Z.-D. Jiang  Clinical Microbiology.
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy  M.L. Mezzatesta, M.M. D'Andrea,
Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci  V. Sakka, S. Tsiodras, L. Galani, A. Antoniadou,
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study  O. Zusman,
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia  E.V. Lemos, F.P. de la Hoz, N. Alvis, T.R. Einarson, E. Quevedo, C. Castañeda, Y. Leon, C. Amado, O. Cañon, K. Kawai  Clinical Microbiology and Infection  Volume 20, Issue 2, Pages 174-180 (February 2014) DOI: 10.1111/1469-0691.12251 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Risk of 30-day mortality comparing patients with carbapenem-resistant Acinetobacter baumannii and patients with carbapenem-susceptible A. baumannii (log rank test, p 0.02). Clinical Microbiology and Infection 2014 20, 174-180DOI: (10.1111/1469-0691.12251) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.